[1] E.J. Hall and D.J. Brenner. Cancer risks from diagnostic radiology. Br. J. Radiol. 81(965) (2008) 362–378.
[2] R.M. Harrison. Introduction to dosimetry and risk estimation of second cancer induction following radiotherapy. Radiat, Meas. 57 1e8 (2013).
[3] N.B. Smith and A. Webb. Introduction to Medical Imaging Physics, Engineering and Clinical Applications. Published in the United States of America by Cambridge University Press, New York, (2011) 70–95.
[5] INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION.Statement on Tissue Reactions. Approved by the Commission on ICRP ref 4825-3093-1464, 21 April (2011).
[6] C.j. Martin. Radiation shielding for diagnostic radiology. Radiat Prot Dosim;165 (1-4)) 2015.( 376–381.
[8] J.D. Harrison, M. Balonov, F. Bochud, C.J. Martin, H-G. Menzel, P. Ortiz-Lopez, R. Smith-Bindman, J.R. Simmonds and R. Wakeford. Annals of the ICRP, The Use of Effective Dose as a 13 Radiological Protection Quantity. ICRP ref 4811-7254-2307, 24 April (2018).
[9] H .Cember and T.E. Johnson. Introduction to Health Physics, Fourth edition, Copyright by The McGraw-Hill Companies. (2009) 203–279.
[10] A.P. Ding. Development of a Radiation Dose Reporting Software for X-ray Computed Tomography (CT). Rensselaer Polytechnic Institute, Troy, New York, (2012).
[11] N. Ryckxa and M..S. Mercea .The use of out-of-plane high Z patient shielding for fetal dose reduction incomputed tomography: Literature review and comparison with Monte Carlo calculations of an alternative optimisation technique. Physica Medica, (2018).